Missitzis相关文献与解析，生知库 | 链接生命科学的每一步

Koufopoulos, Nektarios; Dimas, Dionysios T; Boutas, Ioannis; Kontogeorgi, Adamantia; Sitara, Kyparissia; Sourla, Antigoni; Kittas, Christos; Missitzis, Ioannis L

发表日期：2023

文献求助收藏

Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer

新辅助序贯表柔比星和多西他赛治疗，随后进行手术-放疗，术后根据初始疗效给予多西他赛或吉西他滨/长春瑞滨联合治疗：局部晚期乳腺癌的多模式治疗方法

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-010-0878-8

Kountourakis, Panteleimon; Missitzis, Ioannis; Doufexis, Dimitrios; Zobolas, Vassileios; Pissakas, Georgios; Arnogiannaki, Niki; Maliou, Savoula; Sotiropoulou, Anastasia; Ardavanis, Alexandros

Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy

鉴定和表征 HER-2/neu 表位作为癌症免疫治疗的潜在靶点

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-009-0791-7

Lekka, Eftychia; Gritzapis, Angelos D; Perez, Sonia A; Tsavaris, Nikolaos; Missitzis, Ioannis; Mamalaki, Avgi; Papamichail, Michael; Baxevanis, Constantin N

Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumours

HER-2/neu阳性上皮肿瘤患者中针对HER-2的细胞毒性T细胞前体频率（369-377）

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/sj.bjc.6601244

Sotiropoulou, P A; Perez, S A; Iliopoulou, E G; Missitzis, I; Voelter, V; Echner, H; Baxevanis, C N; Papamichail, M

Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors.

上皮肿瘤患者体内针对 HER-2/neu 癌蛋白 MHC I 类表位的天然 CD8+ T 细胞反应

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-003-0420-9

Sotiropoulou Panagiota A, Perez Sonia A, Voelter Volfgang, Echner Hartmut, Missitzis Ioannis, Tsavaris Nick B, Papamichail Michael, Baxevanis Constantin N

Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes

癌症患者短暂接触抗CD3刺激的同种异体淋巴细胞培养上清液后，可诱导产生抗肿瘤淋巴细胞

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/bjc.1997.510

Baxevanis, C N; Tsiatas, M L; Cacoullos, N T; Spanakos, G; Liacos, C; Missitzis, I; Papadhimitriou, S I; Papamichail, M

Fibroadenoma Arising in Axillary Ectopic Breast Tissue. A Diagnostic Challenge

腋窝异位乳腺组织纤维腺瘤：诊断挑战

Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer

新辅助序贯表柔比星和多西他赛治疗，随后进行手术-放疗，术后根据初始疗效给予多西他赛或吉西他滨/长春瑞滨联合治疗：局部晚期乳腺癌的多模式治疗方法

Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy

鉴定和表征 HER-2/neu 表位作为癌症免疫治疗的潜在靶点

Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumours

HER-2/neu阳性上皮肿瘤患者中针对HER-2的细胞毒性T细胞前体频率（369-377）

Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/ neu oncoprotein in patients with epithelial tumors.

上皮肿瘤患者体内针对 HER-2/neu 癌蛋白 MHC I 类表位的天然 CD8+ T 细胞反应

Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes

癌症患者短暂接触抗CD3刺激的同种异体淋巴细胞培养上清液后，可诱导产生抗肿瘤淋巴细胞